ReviewDermatology research and practice2025
NEXTODERM: Consensus on Dermatophytosis Diagnosis and Management in Nepal.
Review in Dermatology research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising incidence of dermatophytosis, marked by atypical presentations and increasing resistance to treatment, has posed significant challenges to effective clinical management, particularly in regions like Nepal, where localized guidance is limited. In response, a panel of dermatology experts in Nepal conducted a structured literature review and employed a modified Delphi process to develop updated consensus recommendations. These guidelines aim to assist clinicians in making informed decisions regarding diagnosis and treatment, with an emphasis on improving patient outcomes. The consensus highlights key treatment principles, including the potential role of combination therapy and considerations for both localized and more complex presentations of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.